000			03643cam a2200361 a 4500
001			16537755
005			20260102073333.0
008			101115s2011 nyua b 001 0 eng
010			_a 2010048464
020			_a9780195390124 _qhardback) : alk. paper
035			_a16537755
035			_a(OCoLC)682903932
040			_aDLC _cDLC _dYDX _dWLL _dYDXCP _dCDX _dBWX _dDLC
042			_apcc
082	0	0	_a346.0486 _222 _bHO
100	1		_aHo, Cynthia M.
245	1	0	_aAccess to medicine in the global economy : _binternational agreements on patents and related rights / _cCynthia M. Ho.
260			_aNew York : _bOxford University Press, _cc2011.
300			_axviii, 410 p. : _bill. ; _c25 cm.
336			_atext _btxt _2rdacontent
365			_bRs. 13688.00
504			_aIncludes bibliographical references and index.
505	0		_aFrom conception to commercial success -- A limitation on the patent right to exclude : an introduction to international exhaustion -- An introduction to TRIPS -- Freedom under TRIPS : India as an example -- Compulsory licensing under TRIPS : an introduction -- Compulsory license case study : an introduction to competing patent perspectives -- Complicated compulsory licenses : the waiver/article 31bis "solution" -- An overview of "TRIPS-plus" standards -- Beyond patents : protecting drugs through regulatory laws -- Suspensions of in-transit "generic drugs" : a case study of competing perspectives -- A history of access to medicine through the lens of patent perspectives -- Looking toward the future.
520			_aAccess to medicine is a topic of widespread interest. However, some issues that impact such access are presently inadequately understood. In particular, international laws require most nations to provide patents on drugs, resulting in premium prices that limit access. In Access to Medicine in the Global Economy, Professor Cynthia Ho explains such laws and their impact for a diverse group of readers, from scholars and policy makers to students in a variety of disciplines. This book explains and interprets important international agreements, beginning with the landmark Agreement on Trade Related Aspects of Intellectual Property (TRIPS), but also including more recent free trade agreements and the pending Anti-Counterfeiting Trade Agreement (ACTA). Professor Ho addresses controversial topics, such as when a nation can provide a compulsory license, as well as whether a nation may suspend in-transit generic goods. The book also discusses how patent-like rights (such as "data exclusivity") prevent lower-cost generic medicines from entering into the marketplace and provides strategies for minimizing the harm of such rights. Clear explanations and diagrams, frequently asked questions, and case studies make these topics accessible to any reader. The case studies also provide a theory of patent perspectives that helps explain why access to medicine, though a universal goal, remains elusive in practice. The book aims to provide an important first step toward eventual workable solutions by promoting a better understanding of existing and future laws that impact access to medicine.
650		0	_aDrugs _vPatents.
650		0	_aIntellectual property (International law)
650		0	_aPharmaceutical industry _xTechnological innovations.
655		7	_aPatents. _2lcgft _0https://id.loc.gov/authorities/genreForms/gf2011026438
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK
999			_c214189 _d214189